Therapeutic Development Director
Dr Fabrizia Bignami has worked as Therapeutic Development Director at Eurordis since 2002. As such, she has been the administrative coordinator of the EuroBioBank network.
In addition, she is a permanent observer at the Committee for Orphan Medicinal Products (COMP) & and a patient representative member at the Committee for Advanced Therapies (CAT), European Medicines Agency (EMA) London, UK.
A large part of her work focuses on presenting the rare disease patients’ point of view and defending their interest in the orphan drugs, advanced therapies and research fields at national and European level.